Medicinal Plants as Anti-Parasitic Secondary Metabolites: A Special Focus on Acanthamoeba

Vol 1, 2023 - 178148
Lectures
Favorite this paper
How to cite this paper?
Abstract

Good health and well-being (UN-SDG3) is one of the 17 United Nation Sustainable Development Goals to be achieved in 2030. One-World One-health is an integrated approach to balance and optimize the health of people, animals, plants and their shared environment. Plants-based medicine, a high diversity of secondary metabolites with promising biological activities, has been effectively used in healthcare for thousands of years in disease prevention of both humans and animals. In this regard, parasites have been reported of their potentially resistant to the available therapeutic agents as well as no existing vaccines used for preventive measures. This pitfall certainly leads to the discovery of alternative sources of anti-parasitic drugs. To support this, Acanthamoeba spp., waterborne protozoan parasites, are ubiquitous free-living amoebae found in environment such as water and soil. This organism has two main forms: the trophozoite, an invasive stage; and cyst, a highly resistant stage in very harsh conditions. The protozoa are causative agents of amebic keratitis (AK) and granulomatous amebic encephalitis (GAE). So far, those selected Asian medicinal plants (e.g., Curcuma longa, Garcinia mangostana, Annona muricata, Combretum trifoliatum, Knema retusa, and Propolis) have been gained attention in treating Acanthamoeba infections. Our studies demonstrated that these potential medicinal plants play a crucial role with growing interest and future promising anti-Acanthamoeba activities that can be used as alternative therapeutic uses of Asian native plants against Acanthamoeba infections in respond to the sustainable one-health management.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Track
  • 1. Management of diseases and immune response: inflammatory, infectious, non-infectious, autoimmune and lifestyle diseases